GoodRx Holdings [GDRX] vs Veeva Systems [VEEV] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: GoodRx Holdings Inc. wins in 7 metrics, Veeva Systems Inc. wins in 13 metrics, with 0 ties. Veeva Systems Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric GoodRx Holdings Inc. Veeva Systems Inc. Better
P/E Ratio (TTM) 25.67 29.57 GoodRx Holdings Inc.
Price-to-Book Ratio 1.28 3.66 GoodRx Holdings Inc.
Debt-to-Equity Ratio 88.08 1.33 Veeva Systems Inc.
PEG Ratio 6.29 1.22 Veeva Systems Inc.
EV/EBITDA 8.77 20.16 GoodRx Holdings Inc.
Profit Margin (TTM) 3.82% 28.45% Veeva Systems Inc.
Operating Margin (TTM) 18.98% 29.41% Veeva Systems Inc.
EBITDA Margin (TTM) 18.98% 29.41% Veeva Systems Inc.
Return on Equity 4.54% 13.93% Veeva Systems Inc.
Return on Assets (TTM) 4.75% 7.25% Veeva Systems Inc.
Free Cash Flow (TTM) $93.88M $1.42B Veeva Systems Inc.
1-Year Return -25.51% -37.67% GoodRx Holdings Inc.
Price-to-Sales Ratio (TTM) 0.99 8.29 GoodRx Holdings Inc.
Enterprise Value $1.07B $19.85B Veeva Systems Inc.
EV/Revenue Ratio 1.35 6.21 GoodRx Holdings Inc.
Gross Profit Margin (TTM) 91.03% 74.46% GoodRx Holdings Inc.
Revenue per Share (TTM) $2 $20 Veeva Systems Inc.
Earnings per Share (Diluted) $0.09 $5.45 Veeva Systems Inc.
Beta (Stock Volatility) 1.47 1.10 Veeva Systems Inc.
Short % of Float 8.92% 3.90% Veeva Systems Inc.

GoodRx Holdings Inc. vs Veeva Systems Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
GoodRx Holdings Inc.-4.75%-1.75%12.40%35.75%2.55%2.18%
Veeva Systems Inc.-2.31%12.76%4.99%-3.87%-25.94%-18.57%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
GoodRx Holdings Inc.-25.51%-45.83%-92.39%-94.39%-94.39%-94.39%
Veeva Systems Inc.-37.67%-10.59%-39.53%399.40%292.75%292.75%

Performance & Financial Health Analysis: GoodRx Holdings Inc. vs Veeva Systems Inc.

MetricGDRXVEEV
Market Information
Market Cap i$787.92M$26.49B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,461,8252,223,070
90 Day Avg. Volume i1,623,3252,094,990
Last Close$2.81$178.72
52 Week Range$1.77 - $5.81$148.05 - $310.50
% from 52W High-51.64%-42.44%
All-Time High$64.22 (Sep 28, 2020)$343.96 (Aug 02, 2021)
% from All-Time High-95.62%-48.04%
Growth Metrics
Quarterly Revenue Growth-0.02%0.16%
Quarterly Earnings Growth-0.20%0.25%
Financial Health
Profit Margin (TTM) i0.04%0.28%
Operating Margin (TTM) i0.19%0.29%
Return on Equity (TTM) i0.05%0.14%
Debt to Equity (MRQ) i88.081.33
Cash & Liquidity
Book Value per Share (MRQ)$1.81$44.05
Cash per Share (MRQ)$0.76$40.17
Operating Cash Flow (TTM) i$167.90M$1.42B
Levered Free Cash Flow (TTM) i$81.94M$1.05B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: GoodRx Holdings Inc. vs Veeva Systems Inc.

MetricGDRX (Apr 24, 2026)VEEV (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i25.6729.57
Forward P/E i6.2916.30
PEG Ratio i6.291.22
Price to Sales (TTM) i0.998.29
Price to Book (MRQ) i1.283.66
Market Capitalization
Market Capitalization i$787.92M$26.49B
Enterprise Value i$1.07B$19.85B
Enterprise Value Metrics
Enterprise to Revenue i1.356.21
Enterprise to EBITDA i8.7720.16
Risk & Other Metrics
Beta i1.471.10
Book Value per Share (MRQ) i$1.81$44.05

Financial Statements Comparison: GoodRx Holdings Inc. vs Veeva Systems Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGDRX (2025)VEEV (2026)
Revenue/Sales i796.85M3.20B
Cost of Goods Sold i57.60M782.02M
COGS % of Revenue i7.2%24.5%
Gross Profit i739.26M2.41B
Gross Margin i92.8%75.5%
Research & Development i121.03M767.39M
Operating Income (EBIT) i87.49M916.37M
Operating Margin i11.0%28.7%
EBITDA i184.36M944.36M
EBITDA Margin i23.1%29.6%
Pre-Tax Income i56.54M1.19B
Pre-Tax Income % of Revenue i7.1%37.4%
Income Tax i26.10M285.60M
Income Tax % of Revenue i3.3%8.9%
Net Income (Profit) i30.44M908.91M
Profit Margin i3.8%28.4%

Balance Sheet & Liquidity Metrics

MetricGDRX (2025)VEEV (2026)
Cash & Equivalents i261.82M1.42B
Total Current Assets i643.10M8.00B
Total Current Assets % of Revenue i80.7%250.3%
Total Current Liabilities i246.00M1.64B
Total Current Liabilities % of Revenue i30.9%51.2%
Long-Term Debt i533.05M83.71M
Long-Term Debt % of Revenue i66.9%2.6%
Total Shareholders Equity i616.26M7.21B
Retained Earnings i-1.41B4.36B
Retained Earnings % of Revenue i-177.0%136.6%
Property, Plant & Equipment i28.81M0

Cash Flow Statement Comparison

MetricGDRX (2025)VEEV (2026)
Operating Cash Flow i170.70M1.46B
Operating Cash Flow % of Revenue i21.4%45.6%
Capital Expenditures i-3.52MN/A
Free Cash Flow i93.88M1.42B
FCF Margin i11.8%44.3%
Debt Repayment i-5.00MN/A
Common Stock Repurchase i-216.37M-169.95M

Short Interest & Institutional Ownership Analysis

MetricGDRXVEEV
Shares Short i8.69M5.82M
Short Ratio i3.142.75
Short % of Float i8.92%3.90%
Shares Outstanding i341.05M163.78M
Float Shares i95.34M149.83M
% Held by Insiders i12.57%8.57%
% Held by Institutions i58.17%89.44%
% Held by Public i29.26%1.99%

Dividend Analysis & Yield Comparison: GoodRx Holdings Inc. vs Veeva Systems Inc.

MetricGDRXVEEV
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A